
CNST
RhumbLine Advisers’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-52,829
| Closed | -$1.79M | – | 3063 |
|
2021
Q2 | $1.79M | Buy |
52,829
+17,435
| +49% | +$589K | ﹤0.01% | 2004 |
|
2021
Q1 | $828K | Sell |
35,394
-3,156
| -8% | -$73.8K | ﹤0.01% | 2277 |
|
2020
Q4 | $1.11M | Buy |
38,550
+2,454
| +7% | +$70.7K | ﹤0.01% | 2086 |
|
2020
Q3 | $731K | Sell |
36,096
-4,235
| -11% | -$85.8K | ﹤0.01% | 2118 |
|
2020
Q2 | $1.21M | Buy |
40,331
+16,357
| +68% | +$492K | ﹤0.01% | 1964 |
|
2020
Q1 | $754K | Buy |
23,974
+3,643
| +18% | +$115K | ﹤0.01% | 2005 |
|
2019
Q4 | $958K | Buy |
20,331
+471
| +2% | +$22.2K | ﹤0.01% | 2105 |
|
2019
Q3 | $128K | Buy |
19,860
+36
| +0.2% | +$232 | ﹤0.01% | 2847 |
|
2019
Q2 | $243K | Buy |
19,824
+3,512
| +22% | +$43.1K | ﹤0.01% | 2707 |
|
2019
Q1 | $221K | Buy |
+16,312
| New | +$221K | ﹤0.01% | 2711 |
|